Richard Bethlehem is a postdoctoral fellow and research associate at the Autism Research Centre and Brain Mapping Unit at the University of Cambridge in the United Kingdom. He studies integrated neuroimaging and transcriptomics to gain better understanding of the biological underpinnings of typical and atypical neurodevelopment.
Richard Bethlehem
Research associate
University of Cambridge
From this contributor
Q&A with Richard Bethlehem: What goes into a Brainhack
Brainhack conferences offer talks and hands-on tutorials, and unite small groups of interdisciplinary researchers to work on open-source neuroscience projects.
Q&A with Richard Bethlehem: What goes into a Brainhack
How normative modeling can reframe autism’s heterogeneity
Normative modeling could capture variability among autistic people and allow for individualized assessments.
How normative modeling can reframe autism’s heterogeneity
Explore more from The Transmitter
Ehud Ahissar offers a new kind of dualism for neuroscience
He explains how “perceptual dualism” can account for the way we communicate via digital symbols and perceive the world via analog brain processes.
Ehud Ahissar offers a new kind of dualism for neuroscience
He explains how “perceptual dualism” can account for the way we communicate via digital symbols and perceive the world via analog brain processes.
Microglia in hypothalamus help kick-start puberty
In a “surprise” role, the cells regulate the neurons that produce gonadotropin-releasing hormone.
Microglia in hypothalamus help kick-start puberty
In a “surprise” role, the cells regulate the neurons that produce gonadotropin-releasing hormone.
Advances in genetic medicine took center stage at INSAR
The president of the Autism Science Foundation and parent of a child with profound autism reflects on how advances in the treatment of rare gene variants bring hope to many families.
Advances in genetic medicine took center stage at INSAR
The president of the Autism Science Foundation and parent of a child with profound autism reflects on how advances in the treatment of rare gene variants bring hope to many families.